Accelerated Approval Reform Proposals Worry Industry: ‘Science Doesn’t Move The Same Way’

Cartier Esham at House Energy and Commerce Health Subcommittee
BIO's Cartier Esham testifies about accelerated approval and other FDA reforms during a House Energy and Commerce Health Subcommittee hearing. • Source: screenshot
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards